Impact of a Probiotic-Fiber Blend on Body Weight, Metabolic Regulation, and Digestive Function in Obese Adults: A Randomized, Placebo-Controlled, Multicentric Trial

TL;DR

A probiotic-fiber blend significantly reduced body weight and improved metabolic health in obese adults over 90 days.

Contribution

Demonstrates the efficacy of a probiotic-fiber blend in improving obesity-related markers in a large, placebo-controlled trial.

Findings

The probiotic-fiber blend reduced body weight, BMI, and waist/hip circumference significantly compared to placebo.

It also improved metabolic markers like triglycerides, HDL cholesterol, and perceived stress levels.

Digestive health and quality of life showed significant improvements in the treatment group.

Abstract

Introduction: Obesity is closely associated with metabolic syndrome, a cluster of conditions including abdominal obesity, high triglycerides, low high-density lipoprotein (HDL) cholesterol, elevated blood pressure, and impaired glucose metabolism. Emerging research suggests that gut dysbiosis, an imbalance in gut microbiota, plays a key role in metabolic syndrome, influencing insulin resistance, inflammation, and lipid metabolism. The gut microbiome has gained attention for its impact on energy balance, fat storage, and metabolic regulation. This randomized, double-blind, placebo-controlled, multicentric clinical study evaluated the efficacy and safety of probiotic-fiber blend formulation in obese adults.

Methods: Obese adults (body mass index (BMI) 30-<40 kg/m², aged 30-45; male: 46.15%, female: 53.85%) were randomly assigned to receive either the probiotic-fiber blend formulation or a placebo for 90 days, along with lifestyle counseling. Primary outcomes included body weight, BMI, waist/hip circumference, and body fat percentage. Secondary outcomes assessed biochemical parameters, digestive health, quality of life, perceived stress, and metabolic syndrome severity Z (MetS-Z) score. One hundred four participants completed the study.

Results: The probiotic-fiber blend formulation (n = 53) demonstrated statistically significant (p < 0.001) improvements compared to placebo (n = 51), including reductions in body weight (12.01%), BMI (12.14%), waist circumference (9.64%), and hip circumference (9.63%) compared to placebo. Additionally, statistically significant reductions were observed in the MetS-Z score (54.02%), triglycerides (25.75%), and perceived stress (37.62%), along with a notable increase in HDL levels (16.55%). Significant improvements in digestive health and quality of life were also recorded, reinforcing the probiotic-fiber blend efficacy.

Conclusion: The findings provide robust evidence that the probiotic-fiber blend effectively improves anthropometric and biochemical markers in obesity. These results underscore the therapeutic potential of gut microbiome modulation in metabolic health. Further research should explore long-term effects, mechanistic pathways, and broader clinical applications.

Figures